Topiramate pregnancy safety — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Refer promptly to the prescriber for pregnancy-prevention and alternative treatment review
Topiramate is associated with fetal harm and requires careful pregnancy-prevention and treatment review. Patients should not be left to continue until conception without prescriber involvement. Folic acid may be advised in some contexts but does not remove teratogenic risk. Migraine prevention alternatives should be considered by the prescriber.
Reference: MHRA Drug Safety Update; BNF